Chinese Firm Launches New Malaria Drug for Africa's Great Lakes Region
Posted on: Thursday, 23 March 2006, 03:03 CST
Text of report by Kenyan newspaper The Standard website on 23 March
A Chinese pharmaceutical company has launched a new drug to fight malaria in the Great Lakes Region.
Top managers of Beijing Holley-Cotec Pharmaceuticals Company say the new combination therapy drug conformed to the World Health Organisation (WHO) standards.
"In line with the WHO recommendation to combine all artemisinin anti-malaria derivatives, the company formulated the new combination drug, duo-Cotecxin," said Joseph Mu, the company sales director during its launch in Nairobi on Wednesday.
"The drug has already proven very effective and is only a three- day treatment course, taken three tablets on day one and two, then two tablets on day three."
Sources say the WHO has been pushing pharmaceutical companies to develop single dose drugs that can fight the killer disease, especially for children under five years.
Currently, the government required over 100m shillings to fight malaria. Malaria affects over four million people and accounts for more than 50 per cent of in-patients in public hospitals.
It also kills over 30,000 people in the country annually and more than one million across the African continent.
"We shall use Kenya to reach out to other countries in the region," said Mu.
Source: BBC Monitoring Africa
Related Articles
- Malaria Drug May Cause Antibiotic Resistance
- Infections -- Malaria Drug Pipeline Report Provides Detail on the Top 20 Companies With Products in the Early and Late Stage of Development
- Immtech Has Orphan Status for Malaria Drug
- Sanofi Launches Affordable Malaria Drug
- Global Fund to Help Buy Malaria Drugs
- Malaria Drug for Metabolic Syndrome?
- Malaria Drug Seems to Regain Its Punch
- Fake Malaria Drugs Threatening Africa: WHO Expert
- Engineered Yeast May Cut Cost of Malaria Drug
- WHO Says Malaria Drug Misuse May Ruin It
 |
 |
User Comments (0)
RSS Feeds